Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Technology Advancements to propel robust growth of US Diabetes Market

Feb 10, 2011
Share |
 
As per our new research report “US Diabetes Market Analysis”, the US Diabetes market has been growing at a healthy pace for the last decade due to the high prevalence of diabetes in the US, increasing incidence of diabetes associated with Western diets, and rising aging population. Extensive research and profound analysis performed for the market together exhibited a high growth potential market with promising growth prospects inherent for the industry. Owing to the rising direct-to-consumer advertising and improved screening programs, the US diabetes market grew at annual growth of around 17% in 2009.
 
We have done thorough research and prudent analysis of the US Diabetes market and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that the diabetes diagnostic market in the US is moving from traditional finger-prick glucose test to more advanced non-invasive blood glucose testing. Based on some concrete market fundamentals, we anticipate that the US Diabetes market will witness enhanced investments in coming years and will become one of the most dominating market segments in the global diabetes industry.
 
The systematic and thorough research studies the US Diabetes market to give an insight into its various segments, including oral diabetic drugs, insulin market, insulin delivery devices market, and glucose monitoring market. The comprehensive analysis of the market highlights insulin as the current highest share-holder, but future will see glucose monitoring market posting a rapid growth.
 
"US Diabetes Market Analysis" provides thorough research and rational analysis along with reliable statistics of the US diabetes market. The report studies the current development process and its effects on various segments of the industry. It contains exhaustive information about the key market players, government initiatives, and patient profile that will help clients to draw up market strategies and assess opportunity areas in the US diabetes market. The report also includes a section of future projection and cost implications that give a rough idea about the prospective market trends to facilitate clients comprehend how the market will progress in coming years.

For more information visit: http://www.rncos.com/Report/IM299.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports